SUNNYVALE, Calif., Jan. 2 /PRNewswire/ -- Scios Inc. (Nasdaq: SCIO)
announced that Richard B. Brewer, the Company's President and Chief Executive
Officer, will present at the 20th Annual JPMorgan H&Q Healthcare Conference in
San Francisco, California on Monday, January 7, 2002 at 2:00 p.m. (PST).
This presentation will be available to media, investors and the general
public via a live webcast, accessible from Scios' website, http://www.sciosinc.com.
Go to the Investor section, then click on "Events and Presentations" for the
link to the conference webcast. The webcast will be archived for 60 days.
During his approximately half-hour presentation, Mr. Brewer will review
the status of the recent commercial launch of Scios' flagship product,
Natrecor (nesiritide) and outline the Company's strategy and plans for 2002 to
complete its transition to a top-tier commercial-stage biotechnology company.
Scios Inc.
Scios is a biopharmaceutical company developing novel treatments for
cardiovascular and inflammatory disease. The Company's disease-based
technology platform integrates expertise in protein biology with computational
and medicinal chemistry to identify novel targets and rationally design small
molecule compounds for large markets with unmet medical needs.
SOURCE Scios Inc.
 back to top
Related links:
http://www.sciosinc.com
CONTACT:
Wendy Carhart of Scios Inc., +1-408-616-8325;
or Jim Weiss of WeissComm, +1-415-203-0328, for Scios Inc.
|
